Arihant's Securities Limited Overview
Arihant's Securities Limited is a Chennai-based, promoter-controlled, RBI-registered Base Layer NBFC. It was incorporated in 1994 and has been listed on BSE since the mid-1990s. Its constitutional objects cover loan financing, share trading, leasing, hire purchase and related financial services. In practice, however, it now works as a small proprietary investment holding company. Almost all of its ₹38.7 crore balance sheet (FY2026) sits in equity investments, of which ₹35.67 crore is carried at fair value through other comprehensive income (FVOCI). Its income comes from dividends, a little interest, and realised or fair-value gains on securities, so earnings swing with Indian equity markets. The company has no borrowings, pays no dividends, has a very small cost base, and trades at about 0.27 times book value. In September 2025 governance passed to the next promoter generation, when Mrs. Aarisha became Managing Director. Returns on equity are below 1% and there is no stated growth strategy. The stock is best understood as an illiquid, discounted proxy for a closely held equity portfolio.
Company's own description. The company's filings and data-vendor summaries of them describe the business in four consistent ways:
-
It operates in loan financing, trading in shares, and miscellaneous financial services.
-
Its income comes from investments in shares and securities, interest on loans it has financed, and miscellaneous financial activities (Business Standard, JM Financial, mStock).
-
Screener's summary of the FY2024 Annual Report notes that the company currently focuses mainly on share trading.
-
The Directors' Reports for FY2025 (31st Annual Report) and FY2026 (32nd Annual Report) follow standard NBFC reporting formats, including a transfer to the statutory reserve fund.
Tickertape's description adds that the company deals in financial markets, leasing, hire purchase and related activities. This reflects the objects clause in its memorandum rather than current activity.
Independent characterisation. On the evidence of the FY2025 and FY2026 accounts, Arihant's Securities is an equity investment holding vehicle that happens to be licensed as an NBFC. It is not an operating lender in any meaningful sense:
Source: ScanX summary of the FY2026 audited results and annual report (published 18-Aug-2026).
Business model and revenue model. The company earns money in three ways:
-
Dividend yield on a portfolio of listed equities. This is recurring but small at about 0.5% of the investment book.
-
Trading and realised gains on securities. These are lumpy and pro-cyclical.
-
Interest on occasional loans or advances. This is minimal.
There is no product, subscription or licensing revenue. The P&L has no fee or brokerage line, although ScanX's commentary refers to "core brokerage" generically. The company is not a SEBI-registered stockbroker on the evidence reviewed.
Value-chain position. The company is an end investor, a capital allocator using its own balance sheet. It sits at the buy-side end of the capital-markets value chain and has no client-facing intermediation.
Customers and end-markets. The company has no external customer base in the usual sense. Its "end-market" is the Indian listed equity market, mainly BSE- and NSE-listed stocks. Historically it may have had small borrowers in its loan-financing activity. Their identity, number and size are not publicly disclosed.
Cost structure. Total expenses were about ₹0.60 crore in FY2026, made up of employee costs, listing and compliance fees, audit fees, RTA and depository charges, and other administrative costs. Depreciation and finance costs are zero. Executive directors drew no remuneration in FY2026 (ScanX FY26 summary).
Strategy
Stated strategy. The company has published no strategy statement, investor-day material or medium-term plan. Its annual-report Directors' Reports, as reproduced by IIFL, are compliance-oriented. They cover statutory reserve transfers, board evaluation, the independent-director familiarisation programme, payment of listing fees, the corporate governance report and employee particulars. They do not set out growth themes. A Management Discussion & Analysis section is legally required. Its specific content for FY2026 could not be retrieved; ScanX notes that no growth targets were evident in the approved Board's Report.
Implied strategy (analyst characterisation). Based on capital allocation over FY2022–FY2026, the strategy appears to be passive-to-opportunistic stewardship of a concentrated equity portfolio. It has five features:
-
The investment book is held long-term at FVOCI.
-
There is modest trading activity.
-
No leverage is used.
-
No dividends are paid.
-
Overheads are minimal, and executive directors were unpaid in FY2026.
Initiatives in the last 24 months:
Several kinds of initiative were not found at all:
Transformation, cost or digital programmes: none disclosed.
New business launches or platform investments: none disclosed.
ESG commitments: none disclosed.
Guidance or medium-term targets: none. The company gives no financial guidance.
Products & Services
The company offers no branded products, platforms or customer-facing services. Its "portfolio" is a set of capital-deployment activities allowed under its NBFC-ICC registration:
Named flagship offerings: none. The company has no brand architecture.
Product Portfolio
| Activity | Description | Key characteristics | Target counterparty | Status / latest evidence | Pricing model |
|---|---|---|---|---|---|
Long-term equity investments (FVOCI) | Holdings of listed and unlisted equity designated at fair value through OCI | ₹3,566.84 lakh at 31-Mar-2026, the bulk of assets. Gains and losses go to OCI and do not affect reported profit. | Issuer companies (names not disclosed in sources reviewed) | Active; core of the balance sheet (FY2026) | Return comes as dividends plus capital appreciation |
Equity investments at amortised cost | A small residual equity book | ₹93.72 lakh at 31-Mar-2026 | — | Active (FY2026) | Not applicable |
Share trading (proprietary) | Short-term trading in listed shares using own capital | Profits are recognised in "other income" as gains and fair-value changes. Described as the main current focus in the FY2024 Annual Report. | Exchange counterparties | Active; this line drives quarterly volatility (for example, −₹105.41 lakh in Q4 FY2025 and −₹21.05 lakh in Q4 FY2026) | Not applicable |
Loan financing | Loans and advances to third parties | Interest income of only ₹2.65 lakh in FY2026. The size of the loan book is not separately disclosed in the sources reviewed. | — | Dormant or minimal | Interest rate not disclosed |
Leasing / hire purchase | A historical object in the memorandum | No current revenue identified | — | Inactive (no FY2025 or FY2026 income identified) | — |
Miscellaneous financial services | A residual object | No separately disclosed income | — | Not evident | — |
“—” = not publicly disclosed.
Financial Narrative
All figures are standalone, in INR crore unless stated, for fiscal years ending 31 March. Source: Screener.in (C-MOTS), FY2022–FY2026. FY2025–FY2026 detail is cross-checked against the ScanX summaries of the audited results; minor differences come from rounding of lakh figures.
Income Statement
Gross profit is not meaningful for an investment company because there is no cost of goods sold. EPS is the same on a basic and diluted basis because there are no convertible instruments or employee stock options.
Margins and Growth
FY2022 pre-tax margin is computed on total income including the ₹0.30 crore of separately reported other income: 1.35 / (2.15 + 0.30) = 55.1%. On the Screener sales base alone it is 62.79%. FY2022 growth is measured against FY2021 total income of ₹0.47 crore and net profit of ₹0.20 crore.
Revenue CAGR:
-
FY2022 to FY2026 (4 years): −19.3% a year, from ₹2.15 crore to ₹0.91 crore.
-
Screener reports compounded total-income growth of 14% over 5 years, −15% over 3 years and 11% over 10 years.
-
Profit CAGR is 3% over 5 years and −26% over 3 years.
Balance Sheet
Additional detail at the two most recent year-ends (ScanX, from the audited accounts):
Short-term vs long-term debt: both nil in every year. The company is debt-free.
Net debt: negative, meaning a net cash position equal to cash: −₹0.17 crore in FY2025 and −₹0.05 crore in FY2026. Net cash for FY2022–FY2024 is not separately disclosed.
Working capital (proxy): other assets minus other liabilities, in INR crore: FY2022 −0.15; FY2023 0.54; FY2024 0.16; FY2025 −0.05; FY2026 −0.01. The company's operating working capital is essentially nil. Screener reports working-capital days of −24 for FY2026.
Cash Flow
Cash flow and the investment book. Securities purchases and sales by an NBFC whose main activity is investing are often classified within operating activities. That explains why investing cash flow is nil while the investment book moves. The large rises in investments in FY2022 and FY2024 were not funded by cash, since financing flows were nil. They reflect fair-value remeasurement through OCI. This last point is an analyst inference from the balance-sheet arithmetic.
Ratios
Several standard ratios do not apply or cannot be computed here:
ROIC: is the same as ROCE in substance because there is no debt.
Interest coverage: is not meaningful because there is no finance cost.
Net debt / EBITDA: is negative (net cash) and not meaningful.
Current ratio: cannot be computed reliably from the aggregator data. The company does not present a current/non-current split, since NBFC Ind AS Division III balance sheets are presented in order of liquidity. Not publicly disclosed in usable form.
Cash conversion cycle: is not meaningful for an investment company. Screener's figure is simply equal to debtor days.
Screener reports average ROE of 2% over 10, 5 and 3 years, and about 1% for the latest year.
Quarterly Trend (last 13 quarters, INR Cr)
Source: Screener.in quarterly results (BSE filings). Q1 FY2027 figures from ScanX: total revenue ₹28.99 lakh, PBT ₹11.41 lakh, net profit ₹8.56 lakh.
Trend Commentary
Earnings power and volatility. Over the last five years, net profit has moved between ₹0.23 crore and ₹1.15 crore. It has moved closely with the Indian equity market. FY2022 was a strong post-COVID year, FY2024 benefited from a broad mid- and small-cap rally, and FY2025–FY2026 saw cooling. Every year's results include a fourth-quarter loss, in Q4 FY2024, Q4 FY2025 and Q4 FY2026. The likely cause is year-end fair-valuation or realisation of losses on the trading book, such as negative other income of ₹(105.41) lakh in Q4 FY2025. This is a repeated pattern and investors should expect it.
Two balance-sheet step-ups. Net worth rose from ₹5.33 crore (FY2021) to ₹20.32 crore (FY2022), and then to ₹39.69 crore (FY2024), with no equity raised. These step-ups came from upward revaluation of FVOCI equity investments. That makes book value itself market-sensitive. It declined 7.6% between FY2024 and FY2026, from ₹79.38 to ₹73.38 per share.
Shift to a lower tax shield. Effective tax rates were near zero or in the mid-teens up to FY2022, probably because brought-forward losses were being used up. They have been about 25–29% since FY2023, consistent with the standard corporate rate.
Returns. ROE has fallen steadily from 5.7% to 0.6%. The cause is that the equity base doubled through revaluation while profit through the P&L declined. On a total-return basis, including OCI, economic returns in FY2022 and FY2024 were far higher than reported profit. In FY2025 and FY2026 they were negative, since reserves fell by ₹1.64 crore and ₹1.36 crore despite positive profit. This is an analyst inference from reserve movements.
Liquidity. Cash fell 70% to ₹5.13 lakh at 31-Mar-2026, while receivables almost tripled to ₹23.31 lakh. Liquidity depends on the ability to sell listed holdings. That is feasible, but any forced sale would crystallise market risk.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Results by Segment and Segment Margins & Growth (%)
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Total income, single segment (INR Cr) | 2.81 | 1.29 | 0.91 |
Operating profit (INR Cr) | 1.47 | 0.66 | 0.31 |
Profit before tax (INR Cr) | 1.47 | 0.66 | 0.31 |
Operating margin (%) | 52.31 | 51.16 | 34.07 |
YoY growth in total income (%) | 89.86 | -54.09 | -29.46 |
Share of company total (%) | 100 | 100 | 100 |
Income line
| Income line | FY2025 | FY2026 |
|---|---|---|
Dividend income (INR Lakh) | 26.36 | 18.91 |
Interest income (INR Lakh) | 0.25 | 2.65 |
Revenue from operations, total (INR Lakh) | 26.61 | 21.56 |
Other income incl. investment gains and fair-value changes (INR Lakh) | 102.58 | 69.26 |
Total income (INR Lakh) | 129.19 | 90.82 |
Profit before tax (INR Lakh) | 66.19 | 31.43 |
Net profit after tax (INR Lakh) | 48.82 | 23.26 |
Income Statement and Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total income, Screener "Sales" basis (INR Cr) | 2.15 | 1.48 | 2.81 | 1.29 | 0.91 |
Additional other income reported separately (INR Cr) | 0.30 | 0.00 | 0.00 | 0.00 | 0.00 |
Total expenses (INR Cr) | 1.10 | 0.73 | 1.34 | 0.63 | 0.60 |
Operating profit / EBITDA (INR Cr) | 1.05 | 0.75 | 1.47 | 0.66 | 0.31 |
Depreciation (INR Cr) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Finance cost (INR Cr) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit before tax (INR Cr) | 1.35 | 0.75 | 1.47 | 0.66 | 0.31 |
Effective tax rate (%) | 14.81 | 25.33 | 29.25 | 25.76 | 25.81 |
Net profit (INR Cr) | 1.15 | 0.56 | 1.03 | 0.49 | 0.23 |
EPS basic and diluted (INR) | 2.30 | 1.12 | 2.06 | 0.98 | 0.46 |
Dividend per share (INR) | 0 | 0 | 0 | 0 | 0 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansMargin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating / EBITDA margin (%) | 48.84 | 50.68 | 52.31 | 51.16 | 34.07 |
Pre-tax margin on total income (%) | 62.79 | 50.68 | 52.31 | 51.16 | 34.07 |
Net margin on total income (%) | 53.49 | 37.84 | 36.65 | 37.98 | 25.27 |
Total income YoY growth (%) | 357.45 | -31.16 | 89.86 | -54.09 | -29.46 |
Net profit YoY growth (%) | 475.00 | -51.30 | 83.93 | -52.43 | -53.06 |
Balance Sheet and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets (INR Cr) | 21.31 | 22.64 | 41.84 | 39.97 | 38.69 |
Investments (INR Cr) | 20.38 | 20.63 | 39.44 | 38.01 | 36.61 |
Fixed assets (INR Cr) | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 |
Other assets incl. cash and receivables (INR Cr) | 0.84 | 1.92 | 2.31 | 1.87 | 1.99 |
Equity share capital (INR Cr) | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
Reserves (INR Cr) | 15.32 | 16.26 | 34.69 | 33.05 | 31.69 |
Total equity / net worth (INR Cr) | 20.32 | 21.26 | 39.69 | 38.05 | 36.69 |
Total borrowings (INR Cr) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other liabilities (INR Cr) | 0.99 | 1.38 | 2.15 | 1.92 | 2.00 |
Book value per share (INR) | 40.64 | 42.52 | 79.38 | 76.10 | 73.38 |
Goodwill and intangibles (INR Cr) | 0 | 0 | 0 | 0 | 0 |
Balance Sheet
| Item | FY2025 | FY2026 |
|---|---|---|
Cash and cash equivalents (INR Lakh) | 17.15 | 5.13 |
Trade and other receivables (INR Lakh) | 7.94 | 23.31 |
Investments at FVOCI (INR Lakh) | — | 3,566.84 |
Investments at amortised cost (INR Lakh) | — | 93.72 |
Total assets (INR Lakh) | 3,996.94 | 3,868.83 |
“—” = not publicly disclosed.
Cash Flow
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Cash from operating activities (INR Cr) | -0.17 | 0.62 | -0.59 | -0.14 | -0.12 |
Cash from investing activities (INR Cr) | 0.16 | 0.00 | 0.00 | 0.00 | 0.00 |
Cash from financing activities (INR Cr) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net cash flow (INR Cr) | -0.01 | 0.62 | -0.59 | -0.14 | -0.12 |
Capex (INR Cr) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Free cash flow, CFO minus capex (INR Cr) | -0.17 | 0.62 | -0.59 | -0.14 | -0.12 |
Dividends paid (INR Cr) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Buybacks (INR Cr) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE on closing equity (%) | 5.66 | 2.63 | 2.60 | 1.29 | 0.63 |
ROA on closing assets (%) | 5.40 | 2.47 | 2.46 | 1.23 | 0.59 |
ROCE as reported by Screener (%) | 8.19 | 3.61 | 4.82 | 1.70 | 0.83 |
Debt to equity (x) | 0 | 0 | 0 | 0 | 0 |
Asset turnover, total income / closing assets (x) | 0.101 | 0.065 | 0.067 | 0.032 | 0.024 |
Debtor days as reported by Screener | 15.28 | 0.00 | 92.22 | 22.64 | 92.25 |
Investments as a share of total assets (%) | 95.64 | 91.12 | 94.26 | 95.10 | 94.62 |
Total Income by Quarter
| Quarter | Total income | Expenses | PBT | Tax % | Net profit | EPS (INR) |
|---|---|---|---|---|---|---|
Jun-2023 | 0.63 | 0.15 | 0.48 | 0.00 | 0.48 | 0.96 |
Sep-2023 | 1.18 | 0.12 | 1.06 | 0.00 | 1.06 | 2.12 |
Dec-2023 | 0.65 | 0.32 | 0.33 | 0.00 | 0.33 | 0.66 |
Mar-2024 | 0.34 | 0.75 | -0.41 | 104.88 | -0.84 | -1.68 |
Jun-2024 | 0.64 | 0.18 | 0.46 | 0.00 | 0.46 | 0.92 |
Sep-2024 | 0.98 | 0.12 | 0.86 | 0.00 | 0.86 | 1.72 |
Dec-2024 | 0.63 | 0.11 | 0.52 | 0.00 | 0.52 | 1.04 |
Mar-2025 | -0.96 | 0.21 | -1.17 | 14.53 | -1.34 | -2.68 |
Jun-2025 | 0.30 | 0.16 | 0.14 | 21.43 | 0.10 | 0.20 |
Sep-2025 | 0.53 | 0.11 | 0.42 | 23.81 | 0.31 | 0.62 |
Dec-2025 | 0.27 | 0.13 | 0.14 | 28.57 | 0.11 | 0.22 |
Mar-2026 | -0.19 | 0.20 | -0.39 | -25.64 | -0.29 | -0.58 |
Jun-2026 | 0.29 | 0.18 | 0.11 | 27.27 | 0.09 | 0.18 |
Results by Region and Region Margins & Growth (%)
| Region | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
India, total income (INR Cr) | 2.81 | 1.29 | 0.91 |
Rest of world, total income (INR Cr) | 0 | 0 | 0 |
India YoY growth (%) | 89.86 | -54.09 | -29.46 |
Share Price History
| Date | Price (INR) | Market cap (INR Cr) | Notes | Source |
|---|---|---|---|---|
20-Dec-2024 | 33.89 | 17 | 12-month gain of about 96% | Business Standard |
05-May-2025 | 28.62 | 14.31 | 52-week high/low ₹39.90 / ₹16.80 | Simply Wall St |
01-Aug-2025 | 24.06 | 12 | 3-year gain of about 134% | Business Standard |
13-Mar-2026 | 17.53 | about 8.8 | 52-week high/low ₹34.95 / ₹17.21 | Emkay |
08-Jul-2026 | 18.63 | about 9.3 | 30.5% below the 52-week high; under ASM | Trendlyne |
28-Aug-2026 | 19.87 | 10 | P/E 46.4x; P/B 0.27x | Value Research |
08-Oct-2026 | 20.40 | about 10.2 | 43.6% above the 52-week low; under GSM | Trendlyne |
19-Oct-2026 | 19.70 | 9.84 | 52-week high/low ₹26.80 / ₹14.21 | Screener |
Share Price & Returns
| Horizon | Price CAGR / return | Source |
|---|---|---|
1 year | About −7% (Screener); −6.38% (ScanX) | Screener; ScanX |
3 years | 10% CAGR (Screener); 10.74% cumulative (Value Research, Aug-2026). Sources differ on whether the figure is annualised. | Screener; Value Research |
5 years | 22% CAGR | Screener |
10 years | 11% CAGR | Screener |
Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Book value per share (INR) | 40.64 | 42.52 | 79.38 | 76.10 | 73.38 |
EPS (INR) | 2.30 | 1.12 | 2.06 | 0.98 | 0.46 |
Dividend per share (INR) | 0 | 0 | 0 | 0 | 0 |
Valuation Multiples
| Multiple | Arihant's Securities | Peer median | Comment | Source |
|---|---|---|---|---|
P/E (TTM) | 44.7x (Screener, 19-Oct-2026); 46.4x (Value Research, 28-Aug-2026) | 22.5x | Inflated by depressed earnings | Screener; Value Research |
P/B | 0.27x | 2.04x | A deep discount to book | Screener; Value Research |
EV / Sales (total income) | About 10.8x (EV ≈ ₹9.79 crore, i.e. market cap minus ₹0.05 crore cash, divided by TTM income of ₹0.90 crore) | — | Analyst calculation | Derived |
EV / EBITDA | About 35x (₹9.79 crore / TTM operating profit of ₹0.28 crore) | — | Analyst calculation | Derived |
Market cap / investments | About 0.27x (₹9.84 crore / ₹36.61 crore) | — | The holding-company discount is about 73% | Derived |
Dividend yield | 0% | — | — | Screener |
Analyst Conclusions
Management guidance: none provided. Consensus growth expectations: none, since there is no analyst coverage.
Near-term run-rate. FY2027 has started weaker than FY2026. Q1 FY2027 net profit was ₹8.56 lakh against ₹10.36 lakh a year earlier, and trailing-twelve-month net profit is about ₹0.22 crore (Screener). Unless markets deliver large gains, FY2027 earnings are likely to look like FY2026, with roughly ₹0.2–0.3 crore of profit and the risk of another fourth-quarter loss. This is an analyst view, not guidance.
Bull Case
-
Deep value backed by assets. The stock trades at 0.27 times a book value made up almost entirely of equity investments (₹36.6 crore) and carries no debt. Even a partial narrowing of the discount implies large upside: at 0.5 times book the price would be about ₹37.
-
Catalyst from the new leadership. The new MD took over in September 2025. A buyback, a maiden dividend, a lending restart (interest income already rose tenfold in FY2026) or another strategic move could re-rate the stock.
-
Positive leverage to the market. FY2024 showed that a strong equity market can lift income to ₹2.81 crore and net profit to ₹1.03 crore, about 4.5 times the FY2026 level. Revaluation gains would also go straight to book value.
Bear Case
-
A value trap. Over ten years the company has never paid a dividend, has made no buybacks and has averaged an ROE of about 2%. Without a catalyst, the discount to book could persist indefinitely.
-
Book value that is itself volatile. Reserves have fallen about 9% since FY2024. A market correction would cut book value directly through OCI, and the Q4 losses in FY2024–FY2026 show how quickly that happens.
-
Illiquidity and surveillance. ASM and GSM listings, daily volumes of a few hundred shares, no institutional holders and limited disclosure make the stock hard to enter or exit. Cash of only ₹5.13 lakh leaves the company itself with little flexibility.
Key Catalysts and Monitorables (next 12 months)
| # | Item | Expected timing |
|---|---|---|
| 1 | Q2 FY2027 results; the trading window closed on 1-Oct-2026 | Late Oct to mid-Nov 2026 |
| 2 | Q3 FY2027 results | ~Feb 2027 |
| 3 | Q4 FY2027 and full-year results; watch whether the year-end-quarter loss pattern repeats | ~May 2027 |
| 4 | Any announcement of a capital return (dividend or buyback) | Unscheduled |
| 5 | Any strategic statement or fresh business activity under the new MD | Unscheduled; possibly in the FY2027 Annual Report MD&A (~Aug 2027) |
| 6 | Exit from or escalation within BSE ASM/GSM stages | Ongoing |
| 7 | Outcome of the income-tax appeal for AY 2012-13 (₹19.17 lakh) | Unscheduled |
| 8 | Changes in promoter shareholding or any SAST/takeover filing | Quarterly shareholding patterns |
| 9 | Accounting basis: whether the Ind AS 109 exception noted in the Q1 FY2026 results persists | Each results release |
| 10 | RBI NOF compliance and any NBFC regulatory communication | Ongoing |
Concluding Analyst Verdict
Arihant's Securities Limited is a 32-year-old, Chennai-based, BSE-listed, RBI-registered Base Layer NBFC. In economic terms it has become a closely held equity portfolio inside a listed company. About 95% of its ₹38.7 crore of assets is invested in equities, mostly at fair value through OCI. It has no debt and almost no cash, it earns about ₹0.9 crore of total income a year (three-quarters from market gains), and it reported FY2026 net profit of only ₹23.26 lakh. Its reported ROE has fallen to 0.6%, and every one of the last three fiscal years has ended with a loss-making fourth quarter.
The investment case rests almost entirely on the gap between price and book. At ₹19.70, the market values the company at ₹9.84 crore, about 27% of its ₹36.69 crore net worth. That discount reflects real problems, not market neglect alone:
-
no dividends in at least 26 years;
-
no buybacks;
-
minimal disclosure;
-
concentrated family control, with the MD and CFO being mother and daughter;
-
no institutional shareholders;
-
thin trading;
-
current BSE surveillance status.
Book value is not a fixed floor either. It fell 7.6% over FY2025–FY2026 with the market.
The September 2025 succession, which moved the founder to a non-executive role and installed the next generation as Managing Director, is the only real sign of change. It has not yet produced any stated strategy, capital-return policy or operational shift. Unless and until the new leadership commits to returning capital or redeploying the balance sheet productively, the discount is likely to persist. Earnings will keep following the Indian equity market.
Verdict: this is a speculative, illiquid, deep-discount holding-company situation. A clear capital-allocation announcement would materially improve the case. A sustained equity-market downturn would hit both earnings and book value simultaneously. The stock is best monitored for catalysts rather than owned on fundamentals. (This is an analytical assessment for research purposes, not investment advice.)
Sources Consulted
-
Screener.in — Arihants Securities Ltd (BSE 531017): annual P&L, balance sheet, cash flow, ratios, quarterly results, shareholding and BSE announcements (data as of 19-Oct-2026): https://www.screener.in/company/531017/
-
ScanX (Dhan) — FY2026 results summary (18-Aug-2026): https://scanx.trade/stock-market-news/companies/arihants-securities-fy26-results-net-profit-falls-52-23-26-lakh/48607859
-
ScanX — 32nd AGM outcome (09-Sep-2026): https://scanx.trade/stock-market-news/companies/arihants-securities-reappoints-two-directors-32nd-agm/50498379
-
ScanX — Leadership reshuffle (04-Sep-2025) and Q1 FY2026 results (31-Jul-2025): https://scanx.trade/stock-market-news/stocks/arihants-securities-limited-announces-major-leadership-reshuffle/18536092
-
Value Research — stock page (28-Aug-2026): https://www.valueresearchonline.com/stocks/41099/arihants-securities-ltd/
-
Business Standard — company page and financials overview (Dec-2024; Aug-2025): https://business-standard.com/company/arihant-s-secur-5290.html
-
Simply Wall St — stock report and management (May-2025): https://simplywall.st/stocks/in/diversified-financials/bse-531017/arihants-securities-shares
-
Tickertape — quarterly results news: https://www.tickertape.in/stocks/arihants-securities-ARISE
-
Trendlyne — corporate actions and surveillance status (Jul–Oct 2026): https://trendlyne.com/equity/corporate-actions/ARISE/3444/arihants-securities-ltd/
-
IIFL (IndiaInfoline) — Directors' Reports FY2025 and FY2026; board meeting intimations: https://www.indiainfoline.com/company/arihants-securities-ltd/reports/directors-report
-
esi.in — RBI NBFC Base Layer registration snapshot (30-Jun-2024): https://esi.in/finance/nbfc/base-layer/arihants-securities-limited/
-
Emkay Global, Nirmal Bang, mStock, JM Financial, MarketsMojo — company information pages (address, ISIN, RTA, management)
-
MarketScreener — Isha Ramesh director profile: https://www.marketscreener.com/insider/ISHA-RAMESH-A475V8/
-
blinkx — Board of Directors listing: https://blinkx.in/insights/bod/arihants-securities-ltd-board-of-directors
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Category | Tenure / appointment | Background | Age | Source |
|---|---|---|---|---|---|---|
Mrs. Aarisha | Managing Director; chaired the 32nd AGM | Executive, promoter-group | Board member before 2025 as a Non-Executive Director. MD from 04-Sep-2025 for a 5-year term, approved by shareholders. Re-appointed on retirement by rotation at the 9-Sep-2026 AGM. | B.Com. Also a director of ASL Capital Holdings Private Limited. Daughter of the CFO, Mrs. Rajshri Choudhary, and niece of Mr. Nishikant M. Choudhary. | — | ScanX (Reg. 30 filing, 4-Sep-2025; AGM outcome 9-Sep-2026) |
Mr. Nishikant (Nishikanth) Mohanlal Choudhary | Non-Executive Director (promoter) | Non-executive, non-independent | Director since 03-Sep-1994. Managing Director until 04-Sep-2025, about 31 years in the role. | B.A. More than 30 years in the industry. Founding promoter. | About 64 (reported as 63 by Simply Wall St in May 2025) | Simply Wall St; ScanX |
Mr. Prakashchand Ankush Jain | Independent Director | Independent, non-executive | — | — | — | blinkx; ScanX |
Mrs. Isha Ramesh | Independent Director | Independent, non-executive | Appointed 28-Sep-2025 | — | — | MarketScreener; ScanX (AGM attendance) |
MINR Bn. Mohana | Director | — | — | — | — | Emkay; Simply Wall St |
“—” = not publicly disclosed.
Executive Leadership Team
| Name | Title | Notes | Source |
|---|---|---|---|
Mrs. Aarisha | Managing Director (CEO-equivalent) | See above | ScanX |
Mrs. Rajshri Choudhary | Chief Financial Officer | Mother of the MD | ScanX (Sep-2025 Reg. 30 summary) |
Directors' Remuneration
| Item | FY2026 | Source |
|---|---|---|
Executive director remuneration | Nil. Executive directors drew no remuneration in FY2026. | ScanX FY26 annual report summary |
CEO total compensation (salary / bonus / stock / total) | Nil or not disclosed. There are no stock-based plans. | ScanX; Simply Wall St reports "n/a" |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
04-Sep-2025 | Mrs. Aarisha moves from Non-Executive Director to Managing Director (5-year term); Mr. N. M. Choudhary moves from MD to Non-Executive Director | Generational succession within the promoter family, approved at a board meeting held 17:00–17:40 IST |
28-Sep-2025 | Mrs. Isha Ramesh appointed Independent Director | Board refresh, alongside the MD change |
09-Sep-2026 | Mrs. Aarisha re-appointed on rotation; Mr. P. A. Jain re-appointed as Independent Director | Approved with 97.25% of votes cast |
Shareholding Pattern
| Category | Sep-2026 holding (%) | Trend | Source |
|---|---|---|---|
Promoter and promoter group | 46.81 | Up from 40.24% (Mar-2017) to 41.48% (Mar-2019), 45.47% (Mar-2023) and 46.81% (Mar-2024); unchanged since | Screener |
Foreign institutional / FPI | 0.28 | First appeared in the Dec-2024 quarter | Screener |
Domestic institutions (mutual funds, insurers, banks) | 0.00 | — | Screener |
Public (retail and non-institutional) | 52.91 | Down from 59.76% (Mar-2017) | Screener |
Number of shareholders | 3,527 | Peaked at 3,668 (Dec-2024); 2,096 in Mar-2019 | Screener |
Competitive Landscape
Key Competitors
| # | Peer | Listing | Relevance | Source naming the peer |
|---|---|---|---|---|
| 1 | Mehta Integrated Finance Ltd | BSE | Micro-cap finance / investment | Business Standard peer list |
| 2 | Indo-City Infotech Ltd | BSE | Micro-cap, classified in financials | Business Standard |
| 3 | Pasupati Fincap Ltd | BSE | Micro-cap NBFC | Business Standard |
| 4 | Vani Commercials Ltd | BSE | Micro-cap NBFC / investment | Business Standard |
| 5 | V B Desai Financial Services Ltd | BSE | Micro-cap financial services | Business Standard |
| 6 | Minolta Finance Ltd | BSE | Micro-cap NBFC | Business Standard |
| 7 | Anjani Finance Ltd | BSE | Micro-cap NBFC | Business Standard |
| 8 | Goenka Business & Finance Ltd | BSE | Micro-cap NBFC | Business Standard |
| 9 | Arihant Capital Markets Ltd | BSE/NSE | A similar name, but a full-service stockbroker; not a direct comparator. Listed here for disambiguation and as a contrast between a scaled capital-markets franchise and this company. | Analyst addition |
| 10 | Listed investment / holding NBFCs that trade at deep NAV discounts | BSE/NSE | The structural peer group for "discount-to-book" valuation | Analyst addition |
Peer Comparison FY2026
| Metric | Arihant's Securities (FY2026) | Peer 1 |
|---|---|---|
Total income (INR Cr) | 0.91 | — |
Income growth YoY (%) | -29.5 | — |
Operating margin (%) | 34.1 | — |
Net margin (%) | 25.3 | — |
R&D intensity (%) | 0 | Not applicable |
P/E (x) | 46.4 | Peer median 22.5 |
P/B (x) | 0.27 | Peer median 2.04 |



